Skip to content
healthcare.dev

Skytrofa

NDC 73362-014, Lonapegsomatropin-tcgd, injection, powder, lyophilized, for solution, from Ascendis Pharma Endocrinology, Inc..

Product NDC
73362-014
Status
Listed
Labeler
Ascendis Pharma Endocrinology, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761177
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73362-014 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LONAPEGSOMATROPIN1.8 mg/1

Pharmacologic classes

Human Growth Hormone [CS]; Recombinant Human Growth Hormone [EPC]

Package NDCNDC-11Package
73362-014-01733620014014 BLISTER PACK in 1 CARTON (73362-014-01) / 1 CARTRIDGE in 1 BLISTER PACK (73362-014-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTRIDGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9229f871-bc61-4ddc-8122-d126d40e36ac

Use it

Look up 73362-014 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73362-014 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73362-014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.